Effects of PACAP and preconditioning against ischemia/reperfusion-induced cardiomyocyte apoptosis in vitro

Annals of the New York Academy of Sciences

Volumn 1163, Issue , 2009, Pages 512-516

  Roacth E ^a   Weber G ^a   Kiss, P ^a   Horvath G ^a   Toth G ^b   Gasz, B ^a   Ferencz, A ^a   Gallyas Jr , F ^c   Regloacdi D ^a   Racz B ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cleaved caspase 8; Ischemic injury; MAPK; PACAP; Preconditioning

Indexed keywords

CASPASE 8; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL CELL; APOPTOSIS; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; NEWBORN; NONHUMAN; PROTEIN CLEAVAGE; RAT; REPERFUSION INJURY; SURVIVAL RATE;

EID: 65449180377     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03635.x     Document Type: Conference Paper

References (14)

1. Vaudry, D. et al. 2000. Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52 : 269 324. (Pubitemid 30368434)
2. Dehaven, W.I. J. Cuevas. 2004. VPAC receptor modulation of neuroexcitability in intracardiac neurons. J. Biol. Chem. 279 : 40609 40621.
3. Ushiyama, M. et al. 2006. Characterization of the PAC1 variants expressed in the mouse heart. Ann. N. Y. Acad. Sci. 1070 : 586 590. (Pubitemid 44126708)
4. Racz, B. et al. 2007. Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Gen. Comp. Endocrinol. 153 : 115 123.
5. Gasz, B. et al. 2006. Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 27 : 87 94. (Pubitemid 43061041)
6. Suzuki, K. et al. 2001. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104 : I308 313. (Pubitemid 32884820)
7. Umansky, S.R. et al. 1997. Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion. Cell Death Differ. 4 : 608 616. (Pubitemid 127680696)
8. Somogyvari-Vigh, A. D. Reglodi. 2004. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 10 : 2861 2889. (Pubitemid 39172068)
9. Gasz, B. et al. 2006. PACAP inhibits oxidative stress-induced activation of MAP kinase dependent apoptotic pathway in cultured cardiomyocytes. Ann. N. Y. Acad. Sci. 1070 : 293 297. (Pubitemid 44126657)
10. Racz, B. et al. 2008. PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. Regul. Pept. 145 : 105 15. (Pubitemid 350296368)
11. Murry, C.E. et al. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocyardium. Circulation 74 : 1124 1136. (Pubitemid 17174962)
12. Dejda, A. et al. 2008. Inhibitory effect PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J. Mol. Neurosci. 2008 May 28. [Epub, in press].
13. Vaudry, D. et al. 2004. Pituitary adenylate cyclase activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against β-amyloid (25-35)-induced apoptosis. Regul. Pept. 123 : 43 49. (Pubitemid 39424148)
14. Reglodi, D. et al. 2006. Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats. Neuropeptides 41 : 265 274. (Pubitemid 44308347)